SEARCH

SEARCH BY CITATION

References

  • 1
    Findlay JK. An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod 1993;48:1523.
  • 2
    Phillips DJ, Woodruff TK. Inhibin: Actions and signalling. Growth Factors 2004;22:1318.
  • 3
    Farnworth PG, Robertson DM, de Kretser DM, et al. Effects of 31 kilodalton bovine inhibin on follicle-stimulating hormone and luteinizing hormone in rat pituitary cells in vitro: Actions under basal conditions. Endocrinology 1988;122:207213.
  • 4
    Attardi B, Keeping HS, Winters SJ, et al. Rapid and profound suppression of messenger ribonucleic acid encoding follicle-stimulating hormone beta by inhibin from primate Sertoli cells. Mol Endocrinol 1989;3:280287.
  • 5
    Ishida H, Tashiro H, Watanabe M, et al. Measurement of inhibin concentrations in men: study of changes after castration and comparison with androgen levels in testicular tissue, spermatic venous blood, and peripheral venous blood. J Clin Endocrinol Metab 1990;70:10191022.
  • 6
    Peters MA, de Jong FH, Teerds KJ, et al. Ageing, testicular tumours and the pituitary-testis axis in dogs. J Endocrinol 2000;166:153161.
  • 7
    Nishi Y, Haji M, Takayanagi R, et al. In vivo and in vitro evidence for the production of inhibin-like immunoreactivity in human adrenocortical adenomas and normal adrenal glands: Relatively high secretion from adenomas manifesting Cushing's syndrome. Eur J Endocrinol 1995;132:292299.
  • 8
    Vänttinen T, Kuulasmaa T, Liu J, et al. Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells. J Clin Endocrinol Metab 2002;87:42574263.
  • 9
    Nishi Y, Takayanagi R, Yanase T, et al. Inhibin-like immunoreactivity produced by the adrenal gland is circulating in vivo. Fukuoka Igaku Zasshi 2000;91:820.
  • 10
    Sangoi AR, McKenney JK. A tissue microarray-based comparative analysis of novel and traditional immunohistochemical markers in the distinction between adrenal cortical lesions and pheochromocytoma. Am J Surg Pathol 2010;34:423432.
  • 11
    Cho EY, Ahn GH. Immunoexpression of inhibin alpha-subunit in adrenal neoplasms. Appl Immunohistochem Mol Morphol 2001;9:222228.
  • 12
    Zhang PJ, Genega EM, Tomaszewski JE, et al. The role of calretinin, inhibin, melan-A, BCL-2, and C-kit in differentiating adrenal cortical and medullary tumors: an immunohistochemical study. Mod Pathol 2003;16:591597.
  • 13
    Robertson D, Burger HG, Sullivan J, et al. Biological and immunological characterization of inhibin forms in human plasma. J Clin Endocrinol Metab 1996;81:669676.
  • 14
    Grootenhuis AJ, van Sluijs FJ, Klaij IA, et al. Inhibin, gonadotrophins and sex steroids in dogs with Sertoli cell tumours. J Endocrinol 1990;127:235242.
  • 15
    Roser JF, McCue PM, Hoye E. Inhibin activity in the mare and stallion. Domest Anim Endocrinol 1994;11:87100.
  • 16
    Owston MA, Ramos-Vara JA. Histologic and immunohistochemical characterization of a testicular mixed germ cell sex cord-stromal tumor and a Leydig cell tumor in a dog. Vet Pathol 2007;44:936943.
  • 17
    Yu CH, Hwang DN, Yhee JY, et al. Comparative immunohistochemical characterization of canine seminomas and Sertoli cell tumors. J Vet Sci 2009;10:17.
  • 18
    Riccardi E, Grieco V, Verganti S, et al. Immunohistochemical diagnosis of canine ovarian epithelial and granulosa cell tumors. J Vet Diagn Invest 2007;19:431435.
  • 19
    Haji M, Nishi Y, Tanaka S, et al. Evidence for the secretion of inhibin-like immunoreactivity from cultured human adrenal cells. J Endocrinol 1991;128:R13R16.
  • 20
    Spencer SJ, Rabinovici J, Mesiano S, et al. Activin and inhibin in the human adrenal gland. Regulation and differential effects in fetal and adult cells. J Clin Invest 1992;90:142149.
  • 21
    Fogt F, Zimmerman RL, Mulligan N, et al. BCL-2 expression and inhibin-A in adrenal neoplasms: A comparative study. Int J Mol Med 1999;3:271274.
  • 22
    Labelle P, Kyles AE, Farver TB, et al. Indicators of malignancy of canine adrenocortical tumors: Histopathology and proliferation index. Vet Pathol 2004;41:490497.
  • 23
    Fetsch PA, Powers CN, Zakowski MF, et al. Anti-alpha-inhibin: Marker of choice for the consistent distinction between adrenocortical carcinoma and renal cell carcinoma in fine-needle aspiration. Cancer 1999;87:168172.
  • 24
    Arola J, Liu J, Heikkilä P, et al. Expression of inhibin alpha in adrenocortical tumours reflects the hormonal status of the neoplasm. J Endocrinol 2000;165:223229.
  • 25
    Jorda M, De MB, Nadji M. Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas. Appl Immunohistochem Mol Morphol 2002;10:6770.
  • 26
    Pelkey TJ, Frierson HF Jr, Mills SE, et al. The alpha subunit of inhibin in adrenal cortical neoplasia. Mod Pathol 1998;11:516524.
  • 27
    Taniyama H, Hirayama K, Nakada K, et al. Immunohistochemical detection of inhibin-alpha, -betaB, and -betaA chains and 3beta-hydroxysteroid dehydrogenase in canine testicular tumors and normal testes. Vet Pathol 2001;38:661666.
  • 28
    Kawakami E, Hirano T, Hori T, et al. Testicular superoxide dismutase activity, heat shock protein 70 concentration and blood plasma inhibin-alpha concentration of dogs with a Sertoli cell tumor in a unilateral cryptorchid testis. J Vet Med Sci 2007;69:12591262.